Conclusion: The present data suggest that the observed increasing activity of 17HSD type 7 could lead to the increased intracellular production of 17ß-estradiol during disease progression. This was supported by the cDNA microarray screening results, which showed a considerable overexpression of several estrogen up-regulated genes in the LNCaP cell line variant that represents progressive prostate cancer